GSTO2 and hepatocellular carcinoma: GSTO2 is highly expressed in a wide variety of tumors, for example, urothelial carcinoma, head and neck cancer, bladder cancer, epithelial ovarian cancer, breast cancer, and hepatocellular carcinoma [8–13].